Ki-67 labeling index and expression of p53 are non-predictive for invasiveness and tumor size in functional and nonfunctional pituitary adenomas

Alpha subunit in clinically non-functioning pituitary adenomas: An immunohistochemical study

(2017) Michael Solarski et al.   PATHOLOGY RESEARCH AND PRACTICE

Clinical Impact of the Current WHO Classification of Pituitary Adenomas

(2016) W. Saeger et al.   ENDOCRINE PATHOLOGY

Predictors of aggressive clinical phenotype among immunohistochemically confirmed atypical adenomas

(2016) Hasan A. Zaidi et al.   JOURNAL OF CLINICAL NEUROSCIENCE

Silent subtype 3 pituitary adenomas are not always silent and represent poorly differentiated monomorphous plurihormonal Pit-1 lineage adenomas

(2016) Ozgur Mete et al.   MODERN PATHOLOGY

Typical and Atypical Pituitary Adenomas: A Single-Center Analysis of Outcome and Prognosis

(2015) Sabrina Chiloiro et al.   NEUROENDOCRINOLOGY

Histological criteria for atypical pituitary adenomas – data from the German pituitary adenoma registry suggests modifications

(2015) Christian P. Miermeister et al.   Acta Neuropathologica Communications

An analysis of granulation patterns, MIB-1 proliferation indices and p53 expression in 101 patients with acromegaly

(2014) Sauradeep Sarkar et al.   ACTA NEUROCHIRURGICA

Silent corticotroph adenomas

(2014) Odelia Cooper   Pituitary

A new prognostic clinicopathological classification of pituitary adenomas: a multicentric case–control study of 410 patients with 8 years post-operative follow-up

(2013) Jacqueline Trouillas et al.   ACTA NEUROPATHOLOGICA

A Comprehensive Long-term Retrospective Analysis of Silent Corticotrophic Adenomas vs Hormone-Negative Adenomas

(2013) Arman Jahangiri et al.   NEUROSURGERY

Radically resected pituitary adenomas: prognostic role of Ki 67 labeling index in a monocentric retrospective series and literature review

(2013) Sabrina Chiloiro et al.   Pituitary

Results of Immunohistochemical Staining of Cell-Cycle Regulators: The Prediction of Recurrence of Functioning Pituitary Adenoma

(2013) Eun Hee Lee et al.   World Neurosurgery

A classification tree approach for pituitary adenomas

(2012) Alberto Righi et al.   HUMAN PATHOLOGY

Expression of Ki-67, PTTG1, FGFR4, and SSTR 2, 3, and 5 in Nonfunctioning Pituitary Adenomas: A High Throughput TMA, Immunohistochemical Study

(2012) Claudia Ramírez et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Ki-67 Expression for Predicting Progression of Postoperative Residual Pituitary Adenomas: Correlations With Clinical Variables

(2012) Junko MATSUYAMA   NEUROLOGIA MEDICO-CHIRURGICA

Giant Pituitary Adenomas

(2011) Helen Madsen et al.   AMERICAN JOURNAL OF SURGICAL PATHOLOGY

Defining the “edge of the envelope”: patient selection in treating complex sellar-based neoplasms via transsphenoidal versus open craniotomy

(2010) Gabriel Zada et al.   JOURNAL OF NEUROSURGERY

Atypical pituitary adenomas: incidence, clinical characteristics, and implications

(2010) Gabriel Zada et al.   JOURNAL OF NEUROSURGERY

Labeling index in pituitary adenomas evaluated by means of MIB-1: is there a prognostic role? A critical review

(2010) Paulo Henrique Pires de Aguiar et al.   NEUROLOGICAL RESEARCH

The clinical significance of MIB-1 labeling index in pituitary adenomas

(2010) Geeta Chacko et al.   Pituitary

KI-67 IN PITUITARY NEOPLASMS

(2009) Fateme Salehi et al.   NEUROSURGERY

Role of Ki-67 proliferation index and p53 expression in predicting progression of pituitary adenomas

(2008) Roger Gejman et al.   HUMAN PATHOLOGY